Fermentalg has raised US$51 million
Fermentalg has raised US$51 million. US$16 million were raised from its existing shareholders, Demeter, Emertec, and ACE, and US$35 million from news investors, equity funds BPI France, IRDI, Viveris, and Sofiprotéol.
Fermentalg engages in the R&D and production of microalgae by heterotrophic pathway for health, algofuel and aquaculture.
Oaklins’ team in France advised Fermentlag in its fundraising.
Talk to the deal team
Related deals
Vivo Diagnóstico has been acquired by NEXXUS-IBERIA SGEIC, S.A.
NEXXUS-IBERIA SGEIC, S.A. a private equity firm in Spain, has completed its acquisition of a majority stake in Vivo Diagnóstico. With this financial backing from NEXXUS-IBERIA, Vivo will focus on inorganic growth as well as investing in service quality, innovation and efficiency.
Learn moreCreo Medical Group plc has completed a US$15.7 million equity fundraise
Creo Medical Group plc, the provider of pioneering endoscopic healthcare solutions to clinicians and healthcare providers across the world, has completed a US$15.7 million (£12.1 million) equity fundraise.
Learn moreSpringwell Veterinary Surgery has been transferred to an Employee Ownership Trust
Springwell Veterinary Surgery has become employee owned after transferring into an Employee Ownership Trust (EOT).
Learn more